Fiona Rutherford
@Fi_Rutherford
US Healthcare Reporter / [email protected]
18-08-2009 12:04:21
6,7K Tweets
8,0K Followers
1,8K Following
The FDA has cleared lecanemab (Leqembi) - the first treatment clearly shown to slow the advance of Alzheimer’s disease.
The drug will cost $26,500 a year for a person of average weight, Eisai says bloomberg.com/news/articles/… w/ Robert Langreth